A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Authors
Keywords
A2a adenosine receptor, Immune checkpoint, Tumor, T cell, Immunotherapy, PD-1
Journal
Computational and Structural Biotechnology Journal
Volume 13, Issue -, Pages 265-272
Publisher
Elsevier BV
Online
2015-04-11
DOI
10.1016/j.csbj.2015.03.008

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.